Today, Explained A vaccine for RSV
Nov 10, 2022
Keren Landman, a Vox public health reporter and epidemiologist, dives into the alarming rise of RSV cases among children, stressing the strain on healthcare systems. She highlights promising vaccine developments, particularly from Pfizer, that could protect vulnerable infants. The discussion also touches on how changing social behaviors post-pandemic have influenced RSV hospitalization rates. Landman shares insights from past vaccine research breakthroughs, showcasing optimism in combating this respiratory virus.
AI Snips
Chapters
Transcript
Episode notes
RSV's Impact on Babies
- RSV severely impacts babies due to their smaller airways.
- Inflammation and mucus buildup further restrict airflow, making breathing difficult.
RSV Symptoms in Babies
- Babies with RSV exhibit labored breathing, including visible ribcage movement and chest indents.
- This is due to their respiratory systems working harder to get air through constricted airways.
RSV Mortality and Hospitalizations
- RSV is a leading cause of infant mortality in the US and globally.
- It causes significant hospitalizations and deaths in adults over 65, often misdiagnosed as pneumonia.